Advertisement
Screener

CURIS, INC. (CRIS) Material Contracts, 2021

CURIS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2021-03-16: Form 10-K; Exhibit 10.38; Description First Amendment to Collaboration, License and Option Agreement, dated September 7, 2016, by and between Curis, Inc. and Aurigene Discovery Technologies Limited.
  • 2021-03-16: Form 10-K; Exhibit 10.37; Description Collaboration, License and Option Agreement, dated January 18, 2015, by and between Curis, Inc. and Aurigene Discovery Technologies Limited.
FiledFormExhibitDescription
2021-03-1610-K10.38First Amendment to Collaboration, License and Option Agreement, dated September 7, 2016, by and between Curis, Inc. and Aurigene Discovery Technologies Limited
2021-03-1610-K10.37Collaboration, License and Option Agreement, dated January 18, 2015, by and between Curis, Inc. and Aurigene Discovery Technologies Limited

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70